Organogenesis Holdings (ORGO) Other Non Operating Income (2017 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Other Non Operating Income of $38000.0 for Q1 2026, up 1800.0% year-over-year from $2000.0 in Q1 2025, and down 93.82% quarter-over-quarter from $615000.0 in Q4 2025.
Organogenesis Holdings (ORGO) Other Non Operating Income (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Other Non Operating Income history runs 10 years deep, the most recent figure standing at $38000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 1800.0% year-over-year to $38000.0; the TTM figure through Mar 2026 stood at $744000.0 (up 74500.0% YoY), while the FY2025 annual figure was $708000.0, up 3440.0% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $38000.0, down from $615000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $615000.0 in Q4 2025, with the low at -$28000.0 in Q2 2024.
- The 5-year median for Other Non Operating Income is $18000.0 (2025), against an average of $47647.1.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income slumped 516.67% in 2023, then jumped 2377.78% in 2025.
- Organogenesis Holdings' Other Non Operating Income stood at $6000.0 in 2022, then plunged by 516.67% to -$25000.0 in 2023, then slipped by 8.0% to -$27000.0 in 2024, then surged by 2377.78% to $615000.0 in 2025, then sank by 93.82% to $38000.0 in 2026.
- Business Quant data shows ORGO's Other Non Operating Income at $38000.0 in Q1 2026, $615000.0 in Q4 2025, and $18000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Organogenesis Holdings | 241.78 Mn | 194.94 Mn | 20.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26,000.00 |
| Mar 31, 2026 | 38,000.00 |
| Dec 31, 2025 | 615,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 73,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -27,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Jun 30, 2024 | -28,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | -25,000.00 |
| Sep 30, 2023 | 31,000.00 |
| Jun 30, 2023 | 28,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | -21,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Sep 30, 2021 | -19,000.00 |
| Jun 30, 2021 | 18,000.00 |